Archive for June, 2010

• 

  APSS: Armodafinil Safe, Effective with SSRIs

  0June 8, 2010
  By Nancy Walsh, Contributing Writer, MedPage Today, SAN ANTONIO — Patients with obstructive sleep apnea and a comorbid depressive disorder...
• 

  CMSC-ACTRIMS: Cancer Drug Shuts Down MS Activity

  0June 8, 2010
  By Richard Robinson, Contributing Writer, MedPage Today, SAN ANTONIO — Cladribine, an oral drug already marketed for hematologic cancers under...
• 

  ASCO: Olaparib May Have Promise in Breast Cancer

  0June 8, 2010
  By Ed Susman, Contributing Writer, MedPage Today, CHICAGO — Treatment with the investigational poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor olaparib...
• 

  ASCO: New Agents Show Promise in HER2-Positive Breast Cancer

  0June 8, 2010
  By Ed Susman, Contributing Writer, MedPage Today, CHICAGO — A small phase I clinical trial suggests that trastuzumab (Herceptin) conjugated...
• 

  Auxilium reports lower recurrence rate on Xiaflex

  0June 8, 2010
  Associated Press, 06.08.10, NEW YORK – Auxilium Pharmaceuticals Inc. said Tuesday that patients taking its Dupuytren’s contracture treatment Xiaflex in...
• 

  FDA staff eyes safety of Novartis’ MS drug

  0June 8, 2010
  (Reuters) – U.S. regulators expressed concern about potential side effects of Novartis AG’s multiple sclerosis pill in patients most at...
• 

  FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women

  0June 1, 2010
  The U.S. Food and Drug Administration today approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at...
• 

  5th Annual Cardiovascular Risk Assessment Summit

  0June 1, 2010
  January 26 – 27, 2011 in Washington , DC ~ Risk-Benefit Assessment for Diabetes and Oncology Therapies Current Regulatory Perspective...